公开(公告)号：US08519452B2

公开(公告)日：2013-08-27

申请号：US13248173

申请日：2011-09-29

Applicant: Rajesh Kumar Malhan

Inventor： Rajesh Kumar Malhan

IPC: H01L29/812 ,  H01L21/337 ,  H01L29/768

CPC classification number: H01L29/8083 ,  H01L29/0661 ,  H01L29/1608 ,  H01L29/42316 ,  H01L29/66068 ,  H01L29/872

Abstract: A semiconductor device with a JFET is disclosed. The semiconductor device includes a trench and a contact embedded layer formed in the trench. A gate wire is connected to the contact embedded layer, so that the gate wire is connected to an embedded gate layer via the contact embedded layer. In this configuration, it is possible to downsize a contact structure between the embedded gate layer and the gate wire.

Abstract translation: 公开了一种具有JFET的半导体器件。 半导体器件包括形成在沟槽中的沟槽和接触嵌入层。 栅极线连接到触点嵌入层，使得栅极线经由接触嵌入层连接到嵌入式栅极层。 在这种结构中，可以减小嵌入式栅极层与栅极线之间的接触结构。

公开(公告)号：US20130197233A1

公开(公告)日：2013-08-01

申请号：US13638310

申请日：2011-03-29

Applicant: Anu Mittal ,  Anmol Kumar Ray ,  Mahavir Singh Khanna ,  Rajesh Kumar Thaper ,  Mohan Prasad

Inventor： Anu Mittal ,  Anmol Kumar Ray ,  Mahavir Singh Khanna ,  Rajesh Kumar Thaper ,  Mohan Prasad

IPC: C07D401/12

CPC classification number: C07D401/12

Abstract: The present invention relates to the salts of dexlansoprazole in amorphous form. The present invention further relates to processes for the preparation of salts of dexlansoprazole.

Abstract translation: 本发明涉及无定形形式的右兰索拉唑盐。 本发明还涉及右兰索拉唑盐的制备方法。

公开(公告)号：US08455679B2

公开(公告)日：2013-06-04

申请号：US12334398

申请日：2008-12-12

Applicant: Thomas G. Savino ,  Nikolay Lebedinski ,  Rajesh Kumar ,  Calvin T. Peeler

Inventor： Thomas G. Savino ,  Nikolay Lebedinski ,  Rajesh Kumar ,  Calvin T. Peeler

IPC: C07C249/00 ,  C07C291/00

CPC classification number: C08G18/7664 ,  C08G18/10 ,  C08G18/282 ,  C08G18/4825 ,  C08G18/8064 ,  C08G2101/005 ,  C08G2101/0083 ,  C08G2350/00 ,  C08K5/0016

Abstract: A prepolymer system has a monomeric isocyanate content of no greater than about 10% by weight based on 100 parts by weight of the prepolymer system. The prepolymer system comprises a diluent component and a prepolymer component different than and separate from the diluent component. The diluent component has an excess of isocyanate (NCO) functional groups, and comprises the reaction product of a monohydric isocyanate-reactive component and an excess of a first isocyanate component. The first isocyanate component comprises monomeric isocyanates reactive with the monohydric isocyanate-reactive component. The prepolymer component also has an excess of NCO functional groups, and comprises the reaction product of a polyol component and an excess of a second isocyanate component. The prepolymer system can be used to prepare foams via reaction with water. The foams have low density and have excellent adhesion and sound dampening properties for use in cavities of automobile bodies.

Abstract translation: 基于100重量份的预聚物体系，预聚物体系具有不大于约10重量％的单体异氰酸酯含量。 预聚物体系包含稀释剂组分和不同于稀释剂组分的预聚物组分。 稀释剂组分具有过量的异氰酸酯（NCO）官能团，并且包含一元异氰酸酯反应性组分和过量的第一异氰酸酯组分的反应产物。 第一异氰酸酯组分包含与一元异氰酸酯反应性组分反应的单体异氰酸酯。 预聚物组分也具有过量的NCO官能团，并且包含多元醇组分和过量的第二异氰酸酯组分的反应产物。 预聚物体系可用于通过与水反应来制备泡沫。 泡沫具有低密度，并且具有优异的粘附性和阻尼性，用于汽车车身的腔体。

公开(公告)号：US20130130955A1

公开(公告)日：2013-05-23

申请号：US13469813

申请日：2012-05-11

Applicant: Ashok L. Cholli ,  Ashish Dhawan ,  Rajesh Kumar ,  Vijayendra Kumar ,  Suizhou Yang ,  Taizoon Canteenwala

Inventor： Ashok L. Cholli ,  Ashish Dhawan ,  Rajesh Kumar ,  Vijayendra Kumar ,  Suizhou Yang ,  Taizoon Canteenwala

IPC: C10M133/04

CPC classification number: C10M133/14 ,  C10M133/04 ,  C10M141/00 ,  C10M157/00 ,  C10M161/00 ,  C10M2207/024 ,  C10M2207/026 ,  C10M2207/08 ,  C10M2207/284 ,  C10M2207/289 ,  C10M2209/04 ,  C10M2215/062 ,  C10M2215/064 ,  C10M2215/082 ,  C10M2215/14 ,  C10M2217/04 ,  C10M2217/041 ,  C10M2217/046 ,  C10M2219/087 ,  C10M2223/045 ,  C10M2223/049 ,  C10N2230/10 ,  C10N2260/00 ,  C10N2210/02

Abstract: Compositions comprise first antioxidants and first additives, such as, a surface additives, performance enhancing additives and lubricant protective additives and optionally second additives and/or second antioxidants. The compositions are useful to improve lubricants, lubricant oils and other lubricant materials. The compositions and methods generally provide longer shelf lives, increased oxidative resistance, improved quality and/or enhanced performance to lubricants or lubricant oils.

Abstract translation: 组合物包含第一抗氧化剂和第一添加剂，例如表面添加剂，性能增强添加剂和润滑剂保护添加剂以及任选的第二添加剂和/或第二抗氧化剂。 该组合物可用于改善润滑剂，润滑油和其它润滑剂材料。 组合物和方法通常提供更长的保存期限，增加的耐氧化性，改进的质量和/或增强润滑剂或润滑油的性能。

公开(公告)号：US20130122112A1

公开(公告)日：2013-05-16

申请号：US13581463

申请日：2011-03-01

Applicant: Helen M. Burt ,  Donald Brooks ,  Jayachandran Kizhakkedathu ,  Richard Liggins ,  Dechi Guan ,  Lu Ye ,  Clement Mugabe ,  Alan So ,  Martin E. Gleave ,  John K. Jackson ,  Rajesh Kumar Kainthan

Inventor： Helen M. Burt ,  Donald Brooks ,  Jayachandran Kizhakkedathu ,  Richard Liggins ,  Dechi Guan ,  Lu Ye ,  Clement Mugabe ,  Alan So ,  Martin E. Gleave ,  John K. Jackson ,  Rajesh Kumar Kainthan

IPC: A61K47/10 ,  C08G65/333

CPC classification number: A61K47/10 ,  A61K9/0034 ,  A61K9/006 ,  A61K9/5146 ,  A61K31/337 ,  A61K31/407 ,  A61K33/24 ,  A61K47/34 ,  A61K47/60 ,  C08G65/33306 ,  C08G65/33337 ,  C08G65/34 ,  C08G65/48 ,  C08G83/005 ,  C08G83/006 ,  C08G2650/54

Abstract: Herein are provided derivatized hyperbranched polyglycerols (“dHPGs”). The dHPG comprises a core comprising a hyperbranched polyglycerol derivatized with C1C20 alkyl chains and a shell comprising at least one hydrophilic substituent bound to hydroxyl groups of the core, wherein the hyperbranched polyglycerol comprises from about 1 to about 200 moles of the at least one hydrophilic substituent. The dHPGs are for use as agents for the delivery of a drug or other biologically active moiety to the urinary tract, the digestive tract, the airways, the vaginal cavity and cervix and the peritoneal cavity to treat indications such as cancer, which may be useful in the treatment of or the manufacture of a medicament, in the preparation, of a pharmaceutical composition for the treatment of cancer, as a pre-treatment or co-treatment to improve drug uptake in a tissue. Furthermore, there are provided methods of making dHPGs.

Abstract translation: 本文提供衍生的超支化聚甘油（“dHPG”）。 dHPG包含核心，其包含用C1C20烷基链衍生的超支化聚甘油和包含至少一个与核心羟基结合的亲水取代基的壳，其中超支化聚甘油包含约1至约200摩尔的至少一个亲水取代基 。 dHPG用作将药物或其他生物活性部分递送至尿路，消化道，气道，阴道腔和子宫颈以及腹膜腔以治疗诸如癌症的适应症的药剂，其可能是有用的 在制备中用于治疗癌症的药物组合物的治疗或制造中，作为用于改善组织中药物摄取的预处理或共处理。 此外，还提供了制备dHPG的方法。

公开(公告)号：US20130005777A1

公开(公告)日：2013-01-03

申请号：US13508878

申请日：2010-11-12

Applicant: Jagdev Singh Jaryal ,  Swargam Sathyanarayana ,  Rajesh Kumar Thaper ,  Mohan Prasad

Inventor： Jagdev Singh Jaryal ,  Swargam Sathyanarayana ,  Rajesh Kumar Thaper ,  Mohan Prasad

IPC: C07D213/81 ,  A61K31/44

CPC classification number: C07D213/81

Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).

Abstract translation: 本发明提供索拉非尼乙磺酸盐，其制备方法，包含索拉非尼乙磺酸盐的药物组合物及其用于治疗癌症的用途。 式（III）。

公开(公告)号：US08274086B2

公开(公告)日：2012-09-25

申请号：US12458968

申请日：2009-07-28

Applicant: Rajesh Kumar Malhan ,  Yuuichi Takeuchi ,  Jeremy Rashid

Inventor： Rajesh Kumar Malhan ,  Yuuichi Takeuchi ,  Jeremy Rashid

IPC: H01L29/15 ,  H01L31/0256

CPC classification number: H01L29/8083 ,  H01L29/063 ,  H01L29/0692 ,  H01L29/6609 ,  H01L29/66325 ,  H01L29/8611 ,  H01L29/872

Abstract: A wide band gap semiconductor device has a transistor cell region, a diode forming region, an electric field relaxation region located between the transistor cell region and the diode forming region, and an outer peripheral region surrounding the transistor cell region and the diode forming region. In the transistor cell region, a junction field effect transistor is disposed. In the diode forming region, a diode is disposed. In the electric field relaxation region, an isolating part is provided. The isolating part includes a trench dividing the transistor cell region and the diode forming region, a first conductivity-type layer disposed on an inner wall of the trench, and a second conductivity-type layer disposed on a surface of the first conductivity-type layer so as to fill the trench. The first conductivity-type layer and the second conductivity-type layer provide a PN junction.

Abstract translation: 宽带隙半导体器件具有晶体管单元区域，二极管形成区域，位于晶体管单元区域和二极管形成区域之间的电场弛豫区域以及围绕晶体管单元区域和二极管形成区域的外围区域。 在晶体管单元区域中，设置结型场效应晶体管。 在二极管形成区域中，设置二极管。 在电场弛豫区域中，设置隔离部。 隔离部分包括分隔晶体管单元区域和二极管形成区域的沟槽，设置在沟槽的内壁上的第一导电类型层和设置在第一导电类型层的表面上的第二导电类型层 以填补沟槽。 第一导电型层和第二导电型层提供PN结。

公开(公告)号：US20120226150A1

公开(公告)日：2012-09-06

申请号：US13505058

申请日：2010-11-01

Applicant: Marcin A. Balicki ,  Russell H. Taylor ,  Gregory D. Hager ,  Peter L. Gehlbach ,  James Handa ,  Rajesh Kumar

Inventor： Marcin A. Balicki ,  Russell H. Taylor ,  Gregory D. Hager ,  Peter L. Gehlbach ,  James Handa ,  Rajesh Kumar

IPC: A61B6/02 ,  A61B8/13 ,  A61B5/103 ,  A61B6/00

CPC classification number: A61B5/0066 ,  A61B3/102 ,  A61B3/1225 ,  A61B3/13 ,  A61B5/0084 ,  A61B5/061 ,  A61B5/1076 ,  A61B5/743 ,  A61B5/7475 ,  A61B8/5261 ,  A61B90/37 ,  A61B2034/2065 ,  A61B2090/3614 ,  A61B2090/3735 ,  A61B2560/0295 ,  A61F9/007 ,  G02B21/0012 ,  G06F17/241 ,  G06T7/33

Abstract: A visual tracking and annotation system for surgical intervention includes an image acquisition and display system arranged to obtain image streams of a surgical region of interest and of a surgical instrument proximate the surgical region of interest and to display acquired images to a user; a tracking system configured to track the surgical instrument relative to the surgical region of interest; a data storage system in communication with the image acquisition and display system and the tracking system; and a data processing system in communication with the data storage system, the image acquisition and display system and the tracking system. The data processing system is configured to annotate images displayed to the user in response to an input signal from the user.

Abstract translation: 用于外科手术的视觉跟踪和注释系统包括图像获取和显示系统，其被布置成获得感兴趣的外科手术区域的图像流和靠近感兴趣的手术区域的外科器械，并将获取的图像显示给使用者; 跟踪系统，被配置为相对于感兴趣的手术区域跟踪外科器械; 与图像采集和显示系统和跟踪系统通信的数据存储系统; 以及与数据存储系统，图像采集和显示系统以及跟踪系统通信的数据处理系统。 数据处理系统被配置为响应于来自用户的输入信号来注释显示给用户的图像。

公开(公告)号：US08248953B2

公开(公告)日：2012-08-21

申请号：US11782906

申请日：2007-07-25

Applicant: Rajesh Kumar ,  Randall P. J. Ethier

Inventor： Rajesh Kumar ,  Randall P. J. Ethier

IPC: G01R31/08

CPC classification number: H04B3/46

Abstract: A method for detecting and isolating domain specific faults includes comparing a first media quality report for a communication from a first node with a second media quality report for the communication from a second node. The first node comprises an ingress node of a first domain for the communication and the second node comprises an egress node of the first domain for the communication. The method also includes determining that the difference between at least one aspect of the first media quality report and at least one corresponding aspect of the second media quality report exceeds a first threshold. The method further includes, upon determining that the difference exceeds the first threshold, determining a first path between the first node and the second node used by the communication. The method additionally includes isolating at least one source causing the difference between the first media quality report and the second media quality report.

Abstract translation: 用于检测和隔离域特定故障的方法包括将来自第一节点的通信的第一媒体质量报告与用于来自第二节点的通信的第二媒体质量报告进行比较。 第一节点包括用于通信的第一域的入口节点，并且第二节点包括用于通信的第一域的出口节点。 该方法还包括确定第一媒体质量报告的至少一个方面与第二媒体质量报告的至少一个对应方面之间的差超过第一阈值。 该方法还包括：在确定差异超过第一阈值时，确定通信使用的第一节点和第二节点之间的第一路径。 该方法还包括隔离至少一个来源，导致第一媒体质量报告和第二媒体质量报告之间的差异。

公开(公告)号：US08194392B2

公开(公告)日：2012-06-05

申请号：US12830517

申请日：2010-07-06

Applicant: Rajesh Kumar Malhan ,  Naohiro Sugiyama ,  Yuji Noguchi ,  Masaru Miyayama

Inventor： Rajesh Kumar Malhan ,  Naohiro Sugiyama ,  Yuji Noguchi ,  Masaru Miyayama

IPC: H01G4/06

CPC classification number: H01G4/1227 ,  C04B35/4682 ,  C04B35/49 ,  C04B35/495 ,  C04B2235/3206 ,  C04B2235/3215 ,  C04B2235/3236 ,  C04B2235/3255 ,  C04B2235/3279 ,  C04B2235/3284 ,  C04B2235/3298 ,  C04B2235/656 ,  C04B2235/6567 ,  C04B2235/662 ,  C04B2235/77 ,  C04B2235/81 ,  H01G4/0085 ,  H01G4/30

Abstract: A ceramic material has a perovskite structure and is represented by formula of (1−x)ABO3-xYZO3. In the formula, “x” is a real number that is greater than 0 and is less than 1 each of “A,” “B,” “Y,” and “Z” is one or more kinds selected from a plurality of metal ions M other than a Pb ion and alkali metal ions, “A” is bivalent, “B” is tetravalent, “Y” is trivalent or combination of trivalent metal ions, and “Z” is bivalent and/or trivalent metal ions, or a bivalent and/or pentavalent metal ions.

Abstract translation: 陶瓷材料具有钙钛矿结构并由（1-x）ABO 3-x YZO 3的式表示。 在该公式中，“x”是大于0并且小于“A”，“B”，“Y”“的1的实数，”Z“是从多个金属中选择的一种或多种 离子M除了Pb离子和碱金属离子之外，“A”为二价，“B”为四价，“Y”为三价金属离子或三价金属离子的组合，“Z”为二价和/或三价金属离子，或 二价和/或五价金属离子。